Race For Blockbuster Weight-Loss Drugs Pushes Indians To Gray Market
NDTV
The obesity drugs are now a global phenomenon and often in short supply. They've won over the rich and famous and blown open a new market for weight loss drugs.
Stashing boxes of injectables in their carry-on luggage. Buying counterfeit formulas online. Importing boxes from Europe. The race to score blockbuster weight-loss drugs is pushing one of the world's largest populations of obese people to creative lengths.
Breathless media coverage has helped create a frenzy over the treatments. Such is the interest that the anti-obesity medication market could reach $100 billion by 2030, Goldman Sachs Research said. Indians, meanwhile, have simply been watching this from the sidelines.
That's because the latest formulations, Novo Nordisk A/S's Ozempic and Wegovy and Eli Lilly & Co's Mounjaro and Zepbound, won't be available in India anytime soon, amid global supply shortages.